Dexcom (DXCM) executive compensation, 2026 proxy

Jacob Leach, President & Chief Executive Officer, was paid $8M in 2025, up 35% from $5.9M the year before. The CEO-to-median-employee pay ratio was 136:1, on median employee pay of $58,663.

Filed
April 15, 2026
Annual meeting
May 27, 2026
Pay year
2025
Named executives
6
CEO total pay
$8M+35% vs prior year
CEO to median employee
136:1median $58,663
CEO pay in equity
74%$5.9M in awards
Prior say-on-pay support
90%of votes cast
Revenue Growth
16%Up to $4.66 billion
Operating Income Growth
52.0%Up to $911.8 million
Say-on-Pay Support
90%Votes cast in favor
CEO Pay Ratio
136:1For Jacob Leach

How Leach was paid

$8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Stock awards74%Non-equity incentive15%All other compensation1%

Named executive officers

ExecutiveTotal
Jacob LeachPresident & Chief Executive Officer$7,985,960
Kevin SayerExecutive Chairman$16,282,598
Jereme SylvainEVP, Chief Financial Officer$7,077,902
Michael BrownEVP, Chief Legal Officer$6,343,856
Jon ColemanEVP, Chief Commercial Officer$6,745,295
Sadie SternEVP, Chief Human Resources Officer$6,253,131

What changed and why

  • Jacob Leach was promoted to President and Chief Executive Officer effective January 1, 2026.
  • $8MCEO Jacob Leach received total compensation of $7,985,960 for fiscal 2025.
  • $4.66BRevenue grew 16% to $4.66 billion and operating income increased 52.0% to $911.8 million in fiscal 2025.
  • 90%Stockholders showed strong support with approximately 90% voting in favor of the say-on-pay proposal.
  • The ratio of the CEO annual total compensation to the median employee total compensation was 136:1.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.